ClariVest Asset Management’s Achieve Life Sciences ACHV Stock Holding History

ClariVest Asset Management’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-13	Closed	-$62K	–	614
2015 Q3	$62K	Hold	13	–	–	﹤0.01%	497
2015 Q2	$64K	Hold	13	–	–	﹤0.01%	461
2015 Q1	$59K	Hold	13	–	–	﹤0.01%	477
2014 Q4	$63K	Buy	+13	New	+$63.5K	﹤0.01%	438

Other funds holding ACHV

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

EGA

Eagle Global Advisors Houston, Texas $2.78B AUM 26.09% 1-Year Est. Return

AIM

Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return

ClariVest Asset Management's ACHV Position: Q4 2015 in Review

ClariVest Asset Management sold out of Achieve Life Sciences (ACHV) in Q4 2015, closing a stake of 13 shares — an estimated $62K sold.

ClariVest Asset Management first reported a position in ACHV in Q4 2014 and held it in 4 quarters. The position peaked at $64K in Q2 2015. 47 funds tracked by Wall St. Rank hold ACHV as of Q4 2015.

ClariVest Asset Management reported no remaining Achieve Life Sciences position as of Q4 2015 after selling out during the quarter.
ClariVest Asset Management sold 13 Achieve Life Sciences shares in Q4 2015, an estimated $62K.
ClariVest Asset Management first reported a position in Achieve Life Sciences in Q4 2014 and held it in 4 quarters.
ClariVest Asset Management's Achieve Life Sciences position peaked at $64K in Q2 2015.
47 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2015.

Based on ClariVest Asset Management's 13F filing for Q4 2015, filed 27 Jan 2016.